Drs Heidi Waldorf and Doris Day discuss the dermal filler market in the US: what is currently available, what we are likely to see in the next 5 years, and the properties of a hypothetically ‘ideal’ filler.
Wendy Lewis talks to Philippe Schaison, Corporate Vice President & President, U.S. Medical for Allergan, Inc., on the state of aesthetics in light of the pending battle over BOTOX®.
Allergan has unveiled a new treatment protocol for periorbital revitalisation, which incorporates a combination approach of BOTOX® and the VYCROSS…
Balraj Juttla discusses the ever-growing Brazilian aesthetic industry with Mauricio de Maio, as well as his work with Allergan and their new range of dermal fillers
Dario Bertossi reviews the use of dermal fillers as a viable alternative to surgical procedures for facial rejuvenation, and the positive and negative aspects of these treatment options